UPDATE: Wedbush Lowers PT to $25 on Molina Healthcare

A report from Wedbush reiterates its Outperform rating and lowers its price target from $30 to $25 on Molina Healthcare MOH. The report states, “Our price target reflects the growth opportunity from Medicaid expansion ($40B pipeline). Risks to the attainment of our price target include high exposure to government businesses and the company's position as a price taker." MOH closed yesterday at $18.32.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsWedbush Securities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!